Articles, App Notes, Case Studies, & White Papers

  1. AI, Virtual Participants, and the Evolving FDA Regulatory Landscape 5/27/2026

    Understanding emerging requirements around transparency, risk, and governance is essential for responsibly advancing AI-driven innovation in regulated environments.

  2. The Regulatory Governance Gap In Clinical Trial AI 5/21/2026

    Regulators are no longer questioning whether AI belongs in clinical trials; however, they’re demanding a governed infrastructure that makes every AI-driven decision auditable and defensible.

  3. Real-Time Review Is The Most Underrated FDA Story Of The Year 5/21/2026

    The FDA’s real-time review pilot signals a massive shift in clinical operations, where continuously regulator-ready data becomes the foundation of future trial execution.

  4. Capture Was Step One. Execution Is Step Two. 5/21/2026

    Electronic data capture transformed clinical trials, but advancing a study depends on decision workflows that interpret data, coordinate teams, and determine meaningful next actions.

  5. Optimizing Wearable Adherence In A Phase 3 Oncology Trial 5/15/2026

    Long-term wearable monitoring only works if patients keep wearing the device, and in oncology trials, that’s easier said than done.

  6. The Real Reason Sites Haven't Digitized 5/11/2026

    Reducing site burden doesn’t require major change. Streamlining one workflow can boost efficiency, support compliance, and free staff to focus on patients.

  7. The Site-Sponsor Digital Divide Is Slowing Clinical Trial Innovation 5/11/2026

    Clinical trial site digitization often stalls due to operational, cultural, and structural barriers. Site-centered workflows can overcome these, boosting efficiency, visibility, and execution.

  8. Why Site Training Still Slows Site Activation 5/11/2026

    Effective site training relies on clear, accessible, up-to-date materials that reflect real workflows — keeping sites aligned, compliant, and confident throughout the study lifecycle.

  9. Your CRAs Aren't Monitoring. They're Managing Workarounds. 5/11/2026

    CRA productivity rises when monitoring shifts from manual tasks to streamlined access, standardized workflows, and proactive oversight — freeing time for engagement, data quality, and patient safety.

  10. IRT vs. RTSM: What Sponsors Need To Know When Choosing Clinical Trial Technology 5/6/2026

    Mastering the nuances between IRT and RTSM allows trial teams to move past confusing jargon and focus on the supply intelligence and randomization logic essential for study integrity.